Clinical Neurophysiology
Volume 110, Issue 10 , Pages 1700-1707 , 1 October 1999

The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients

  • M Pierantozzi

      Affiliations

    • Clinica Neurologica Università di Tor Vergata, Rome, Italy
    • IRCCS Ospedale S. Lucia, Via Ardeatina 306, 00179 Rome, Italy
    • ,
  • P Mazzone

      Affiliations

    • Divisione di Neurochirurgia Ospedale CTO ASL RMC, Rome, Italy
    • ,
  • A Bassi

      Affiliations

    • IRCCS Ospedale S. Lucia, Via Ardeatina 306, 00179 Rome, Italy
    • ,
  • P.M Rossini

      Affiliations

    • Divisione di Neurologia Ospedale Fatebenefratelli, Isola Tiberina, Rome, Italy
    • ,
  • A Peppe

      Affiliations

    • IRCCS Ospedale S. Lucia, Via Ardeatina 306, 00179 Rome, Italy
    • ,
  • M.G Altibrandi

      Affiliations

    • Divisione di Neurochirurgia Ospedale CTO ASL RMC, Rome, Italy
    • ,
  • A Stefani

      Affiliations

    • Clinica Neurologica Università di Tor Vergata, Rome, Italy
    • IRCCS Ospedale S. Lucia, Via Ardeatina 306, 00179 Rome, Italy
    • ,
  • G Bernardi

      Affiliations

    • Clinica Neurologica Università di Tor Vergata, Rome, Italy
    • IRCCS Ospedale S. Lucia, Via Ardeatina 306, 00179 Rome, Italy
    • ,
  • P Stanzione

      Affiliations

    • Clinica Neurologica Università di Tor Vergata, Rome, Italy
    • IRCCS Ospedale S. Lucia, Via Ardeatina 306, 00179 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-06-515-01462; fax: +39-06-592-2086

,Accepted 20 April 1999.

References 

  1. Abbruzzese G, Dall'Agata D, Morena M, Reni L, Favale E. Abnormalities of parietal and prerolandic somatosensory evoked potentials in Huntington's disease. Electroenceph clin Neurophysiol. 1990;77:340–346
  2. Abbruzzese G, Tabaton M, Morena M, Dall'Agata D, Favale E. Motor and sensory evoked potentials in progressive supranuclear palsy. Mov Disord. 1991;6:49–54
  3. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13:266–271
  4. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex (Review). Annu Rev Neurosci. 1986;9:357–381
  5. Benabid AL, Pollak P, Gervason C, Hoffman D, Gao DH, Hommel M, et al. Long term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 1991;337:403–406
  6. Cheron G, Borenstein S. Specific gating of the early somatosensory evoked potentials during active movement. Electroenceph clin Neurophysiol. 1987;67:537–548
  7. Cheron G, Borenstein S. Mental movement simulation affects the N30 frontal component of the somatosensory evoked potential. Electroenceph clin Neurophysiol. 1992;84:288–292
  8. Cheron G, Piette T, Thiriaux A, Jacquy J, Godaux E. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on frontal N30 wave. Electroenceph clin Neurophysiol. 1994;92:491–501
  9. Cohen LG, Starr A. Specific gating of the early somatosensory evoked potentials. Neurology. 1985;35:691–698
  10. Cohen LG, Starr A. Localization, timing and specificity of gating of somatosensory evoked potentials during active movement in men. Brain. 1987;110:451–468
  11. Desmedt JE, Bourguet M. Colour imaging of parietal and frontal somatosensory potential fields evoked by stimulation of median or posterior tibial nerve in men. Electroenceph clin Neurophysiol. 1985;62:1–17
  12. Desmedt JE, Cheron G. Non-cephalic reference recording of early somatosensory evoked potentials to finger stimulation in adult or aging normal man: differentiation of widespread N18 and controlateral N20 from the prerolandic P22 and N30 components. Electroenceph clin Neurophysiol. 1981;52:553–570
  13. Desmedt JE, Nguyen TH, Bourguet M. Bit-mapped color imaging of humans evoked potentials with reference to the N20, P22, P27 and N30 somatosensory response. Electroenceph clin Neurophysiol. 1987;68:1–19
  14. Fahn S, Elton RL. UPDRS Development Committee. Unified Parkinson's disease rating scale. In:  Fahn S,  Marsden CD,  Calne DB,  Goldstein M editor. Recent development in Parkinson's disease. II:Florham Park, New York: McMillan Healthcare Information; 1987;p. 153–163293–304
  15. Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol. 1991;30:365–374
  16. Grafton ST, Waters C, Sutton J. Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study. Ann Neurol. 1995;37:776–783
  17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442
  18. Hughes AJ, Lees AJ, Kempster PA, Stern GM. Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet. 1990;1:1262–1263
  19. Jenkins IH, Fernandez W, Playford ED, Lees AJ, Frackowiak RSJ, Passingham RE, et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol. 1992;32:749–757
  20. Krack P, Pollak P, Limousine D, Hoffmann J, Xie J, Bemnazzouz A, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain. 1998;121:451–457
  21. Limousin P, Greene J, Pollak P, Rothwell J, Benabid A, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol. 1997;283–291
  22. Mauguiere F, Desmedt JE. Focal capsular vascular lesions can selectively deafferent the prerolandic or the parietal cortex: somatosensory evoked potential evidence. Ann Neurol. 1991;30:71–75
  23. Mauguiere F, Desmedt JE, Courjon J. Astereognosis and dissociated loss of frontal or parietal components in somatosensory evoked potentials in hemispheric lesions. Brain. 1983;106:271–311
  24. Phawa R, Wilkinson S, Smith RN, Lyons K, Miyawaki E, Koller WC. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology. 1997;49:249–253
  25. Playford ED, Jerkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol. 1992;32:151–161
  26. Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, MarcVirgnes JP, et al. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional blood flow changes during finger movements and effects of apomorphine. Arch Neurol. 1992;49:144–148
  27. Rascol O, Sabatini U, Chollet F, Fabre N, Senard JM, Montastruc JL, et al. Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J Neurol Neurosurg Psychiatry. 1994;57:567–571
  28. Rossini PM, Babiloni F, Bernardi G, Cecchi L, Johnson PB, Malentacca A, et al. Abnormalities of short-latencies somatosensory evoked potentials in parkinsonian patients. Electroenceph clin Neurophysiol. 1989;74:277–289
  29. Rossini PM, Paradiso C, Zarola F, Bernardi G, Caramia MD, Mangari L, et al. Brain excitability and long latency muscular arm responses: non invasive evaluation in healthy and parkinsonian subjects. Electroenceph clin Neurophysiol. 1991;81:454–465
  30. Rossini PM, Traversa R, Boccasena P, Martino G, Passatelli F, Pacifici L, et al. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components. Neurology. 1993;43:2495–2500
  31. Rossini PM, Bassetti MA, Pasqualetti P. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism. Electroenceph clin Neurophysiol. 1995;96:234–247
  32. Rossini PM, Babiloni F, Babiloni C, Ambrosini A, Onorati P, Urbano A. Topography of spatially enhanced human short-latency somatosensory evoked potentials. NeuroReport. 1997;8:991–994
  33. Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 1983;275:321–328
  34. Stanzione P, Traversa R, Pierantozzi M, Semprini R, Loberti M, Peppe A, et al. SEPs N30 amplitude in pharmacologically induced rigidity: relationship with the clinical status. Eur J Neurol. 1997;4:24–38
  35. Stanzione P, Mazzone P, Peppe A, Pierantozzi M, Stefani A, Bassi A, et al. Antiparkinsonian and anti levodopa induced dyskinesia effects obtained by stimulating the same site within the GPi in Parkinson's disease. Neurology. 1998;51:1776–1777
  36. Stibe C, Lees AJ, Stern G. Subcutaneus infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations. Lancet. 1987;1:871
  37. Topper R, Schwartz M, Pordoll K, Domges F, Noth J. Absence of frontal somatosensory evoked potentials in Huntington's disease. Brain. 1993;116:87–101

PII: S1388-2457(99)00113-3

Clinical Neurophysiology
Volume 110, Issue 10 , Pages 1700-1707 , 1 October 1999

Article Tools

* Image Usage & Resolution